Cassava Sciences, Inc.
SAVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $89,423 | $68,032 | $0 |
| Gross Profit | $0 | -$89,423 | -$68,032 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $69,637 | $89,423 | $68,932 | $24,813 |
| G&A Expenses | $71,809 | $16,534 | $11,988 | $8,055 |
| SG&A Expenses | $71,809 | $16,534 | $11,988 | $8,055 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$89,423 | -$68,932 | $0 |
| Operating Expenses | $141,446 | $16,534 | $11,988 | $32,868 |
| Operating Income | -$141,446 | -$105,957 | -$80,020 | -$32,868 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $117,104 | $8,740 | $3,774 | $483 |
| Pre-Tax Income | -$24,342 | -$97,217 | -$76,246 | -$32,385 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$24,342 | -$97,217 | -$76,246 | -$32,385 |
| % Margin | – | – | – | – |
| EPS | -0.53 | -2.32 | -1.8 | -0.81 |
| % Growth | 77.2% | -28.9% | -122.2% | – |
| EPS Diluted | -0.52 | -2.32 | -1.8 | -0.81 |
| Weighted Avg Shares Out | 46,329 | 41,932 | 40,202 | 39,405 |
| Weighted Avg Shares Out Dil | 46,604 | 41,932 | 40,202 | 39,405 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,510 | $7,833 | $2,777 | $49 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,132 | $1,530 | $1,301 | $534 |
| EBITDA | -$141,146 | -$104,427 | -$78,719 | -$32,334 |
| % Margin | – | – | – | – |